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Purpose: To describe and analyze the microstructural changes in herpetic stromal keratitis
(HSK) observed in vivo by spectral-domain ocular coherence tomography (SD-OCT) at
different stages of the disease.
Methods: A prospective, cross-sectional, observational, and comparative SD-OCT analysis
of corneas with active and inactive keratitis was performed, and the pathologic differences
between the necrotizing and non-necrotizing forms of the disease were analyzed.
Results: Fifty-three corneas belonging to 43 (81.1%) women and 10 (18.8%) men with a mean
age of 41.0 years were included for analysis. Twenty-four (45.3%) eyes had active keratitis,
and 29 (54.7%) had inactive keratitis; the majority (83.0%) had the non-necrotizing form.
Most corneas (79.1%) with active keratitis showed stromal edema and inflammatory infiltrates.
Almost half of the active lesions affected the visual axis, were found at mid-stromal depth,
and had a medium density. By contrast, corneas with inactive keratitis were characterized
by stromal scarring (89.6%), epithelial remodeling (72.4%), and stromal thinning (68.9%). In
contrast to non-necrotizing corneas, those with necrotizing HSK showed severe stromal
scarring, inflammatory infiltration, and thinning. Additionally, most necrotizing lesions (77.7%)
affected the visual axis and had a higher density (P = 0.01).
Conclusion: Active HSK is characterized by significant epithelial and stromal thickening
and the inactive disease manifests epithelial remodeling at sites of stromal thinning due to
scarring. Necrotizing keratitis is characterized by distorted corneal architecture, substantial
stromal inflammatory infiltration, and thinning. In vivo SD-OCT analysis permitted a better
understanding of the inflammatory and repair mechanisms occurring in this blinding corneal
disease.
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Herpetic keratitis is the major cause of corneal
blindness in many developed countries, with
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the stromal form representing almost one-third
(29.5%) of all cases.[1, 2] Herpetic stromal keratitis
(HSK) accounts for up to 44% of recurrences,
and the risk for recurrent infection increases
after multiple attacks of keratitis.[3, 4] Therefore,
HSK represents a significant burden of ocular
disease, being the most feared presentation
of herpetic corneal infection due to its severe
damage to the cornea.[5] Most cases of HSK
present as non-necrotizing.[6] Non-necrotizing
HSK or immune stromal keratitis is characterized
by stromal inflammation leading to scarring,
thinning, and vascularization of the cornea.[7, 8] The
direct viral antigen stimulation of HSV-1-specific
CD4𝛼𝛽 T-lymphocytes probably drives stromal
inflammation. Other likely pathogenic mechanisms
are autoantigens unmasked and mimicked by
HSV-1 corneal infection, bystander cytokine
activation of CD4𝛼𝛽 T-cells, or a combination
of all these mechanisms.[9–11] On the other
hand, the necrotizing form is characterized by
ulcerations, dense leukocytic stromal infiltration,
and necrosis that may rapidly progress to corneal
perforation.[9, 10] Both viral antigens and replicating
virions have been implicated in the pathogenesis
of this form of keratitis.[12, 13]
Most of our knowledge of the pathologic
alterations seen in HSK is based on direct slit-
lamp observations and histopathologic findings
from fixed tissues.[14, 15] Recently, in vivo confocal
microscopy analysis of herpetic keratitis has
shown that a significant and gradual decrease in
superficial epithelial cell density is correlated
with decreased corneal innervation.[16] The
same imaging technique has also been used
to monitor the inflammatory process of HSK.[17]
Spectral-domain optical coherence tomography
(SD-OCT) provides noncontact in vivo corneal
cross-sectional, high-resolution images that
allow a detailed delineation of the cornea.[18]
The high speed of the technique permits the
acquisition of high-definition frames with few
motion artifacts.[19, 20] Enlarged sections of
averaged images permit the discrimination of
all corneal layers.[21] SD-OCT also enables more
accurate measurements of the corneal thickness
at a particular point, or in a 6 mm diameter
pachymetry map even in the presence of corneal
irregularity or opacity.[8, 22]
The primary purpose of the present study was
to describe and analyze themicrostructural corneal
alterations observed by SD-OCT during the active
and inactive stages of HSK and to compare those
changes between non-necrotizing and necrotizing
keratitis. This analysis adds to our understanding
of the inflammatory and repair mechanisms of the
cornea in this sight-threatening disease.
METHODS
This is a prospective, cross-sectional, descriptive,
comparative, and observational study of patients
diagnosed with HSK based on clinical findings.
The inclusion criteria for the disease diagnosis
were based on previous medical history, clinical
manifestations, and therapeutic response to
herpes-specific antiviral therapy. Past medical
histories of mucocutaneous herpetic vesicular
eruption, oral herpetic stomatitis, and herpetic
blepharoconjunctivitis were all considered
for the diagnosis. Previous or current clinical
manifestations consisting of herpetic epithelial
and/or stromal keratitis, characterized by dendritic
or geographic ulceration, inflammatory stromal
infiltration, stromal edema, and hypoesthesia
were required for inclusion in the study. Corneal
examination parameters performed on all patients
included a refractive power analysis (OPD-
Scan III, Nidek Co., LTD. Japan), a detailed
comparative correlative slit lamp exam, including
colored photographs and schematic drawings
of the corneal lesions, as well as qualitative
esthesiometry and fluorescein and lissamine green
staining. Therapeutic response to conventional
antiviral therapy was also considered necessary
for the diagnosis.[7–9]
The exclusion criteria consisted of an
unwillingness to participate in the study, any
previous history of corneal pathology such
as trauma, chemical burns, bacterial, fungal,
adenoviral, or protozoan infection, and other forms
of inflammatory or infectious external disease.
Corneas with disciform keratitis, endotheliitis,
anterior uveitis, or neurotrophic keratitis were
excluded from the analysis. Additionally, cases with
a doubtful diagnosis or with atypical HSK defined
as corneas where dendritic or geographical ulcers,
epithelial infiltration, and hypoesthesia were not
evident were excluded from the analysis.
Before inclusion in the study, all patients read
and signed an informed consent form previously
approved by the Research and Ethics Committees
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of our institution according to the tenets of the
Declaration of Helsinki.
Corneas included for analysis were divided
according to the pathophysiologic classification
into immunologic, or non-necrotizing, and
infectious, or necrotizing, HSK.
Corneas were also categorized as inactive
when corneal opacity and scarring due to
herpetic keratitis was evident, and no signs
or symptoms of inflammation or infection
were present. Active disease was considered
when patients experienced related symptoms,
including red eye, blurred vision, foreign body
sensations, photophobia, tearing, and pain.
Additionally, signs of active inflammation,
such as ciliary injection, corneal ulceration,
active vascularization, inflammatory infiltration,
stromal edema or melting, and keratic
precipitates were observed under slit-lamp
examination.
SD-OCT (RTVue-100®, Optovue, Inc., Fremont,
CA, USA) analysis was performed by the same
technician (SIS) to each eye using a corneal
module adaptor (CAM) L-lens (15 µm) and S-lens
(10 µm), depending on whether the full extent or
the details of corneal lesions, respectively, were
analyzed as requested in a drawing scheme.
While the wide-angle CAM L-lens provides a
scan width of up to 6 mm and a transverse
resolution of 15 μm, the high magnification CAM
S-lens provides a scan width of up to 4 mm and
a transverse resolution of 10 μm. Additionally,
the corneal adaptor module software (version
5.5) automatically processes five consecutive
sets of eight high-definition meridional scans, of
which the three most consistent sets are used
to provide a 6 mm scan diameter pachymetry
map and the minimum corneal thickness point.[20]
Specific measurements of corneal epithelial
and stromal thicknesses were also performed
manually at the site of the lesions. Cursors were
always placed perpendicular to the anterior
corneal surface at the point of measurement.
Four thickness measurements were considered
for analysis: the central corneal thickness (CCT),
minimal corneal thickness (MCT), corneal thickness
at the site of the lesion (CTL), and corneal
epithelial thickness over the stromal lesion
(CETL).
Multiple high-resolution meridional scans were
performed for each corneal lesion related to
HSK according to a drawing scheme prepared
from direct observations under the slit lamp.
Representative scan images were selected for
morphologic analysis by one of us (ARG) based on
representative slit-lamp observations and corneal
color photographs registered just before sending
the patients for SD-OCT analysis. Corneal lesions
consisting of inflammatory infiltrates and stromal
edema from eyes with active keratitis and scars
or leukomas from eyes with inactive disease were
studied.
Stromal edema assessed by SD-OCT was
defined as a hypodense area (grade I, < 33%)
within the involved corneal stroma, accompanied
by a ≥ 20% increase in thickness compared to
the adjacent unaffected stroma. Stromal thinning
was defined as a ≥ 15% thickness reduction
compared to an immediate adjacent healthy
area. Inflammatory infiltrate was described as
a hyperdense lesion (grades II, 34–66%, and
III, > 67%) within the involved corneal stroma,
accompanied by a ≥ 10% increase in the thickness
of an adjacent unaffected area.
The following measurement parameters were
analyzed: localization (central = 5 mm zone,
or paracentral/peripheral = 5–12 mm zone);
percentage of surface extension (small ≤ 25%,
medium = 25–45%, and large ≥ 45%); depth
(superficial ≤ 150 µm, medial = 150–350 µm,
and deep ≥ 350 µm); and density, which
was analyzed using the color scale provided
by the SD-OCT device. For this purpose, a
classification system was created to quantify the
density of each lesion by examining the warm
tones (white, red, orange) that predominated
in the image, which corresponded to the
percentage of backscattering and reflective
properties of the tissue analyzed (grade I,
< 33%; grade II, 34–66%; and grade III, >
67%).
Statistical analysis was performed using
the SPSS software version 23.0 (SPSS Inc.
Chicago, IL. USA). A Shapiro-Wilk test was
performed to explore the normality of variable
distribution; observing that the pachymetric
measurements, density, and depth values of the
corneal lesions were not distributed normally,
nonparametric tests (Mann–Whitney U-test) were
used to compare the difference in medians. A
P-value < 0.05 was considered as statistically
significant.
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RESULTS
SD-OCT scanning was performed on 53 corneas
of patients with unilateral HSK. These corneas
belonged to 43 (81.1%) women and 10 (18.9%) men.
The mean age at presentation was 41.0 years
(range, 7 to 77 years).
Most eyes (83.1%) had immune or non-
necrotizing HSK, and only nine (16.9%) eyes
had the infectious or necrotizing form. Regarding
the inflammatory status at the time of analysis, 24
(45.3%) eyes had active keratitis and 29 (54.7%)
had inactive keratitis.
In the group of patients with active keratitis, 17
(70.8%) corneas belonged to women and 7 (29.1%)
to men with a mean age of 42.2 years (range, 9–77
years). The most frequent symptoms found in these
patients were red eye, tearing, and photophobia,
and the most frequent signs were red eye, stromal
edema, and hypoesthesia.
Meanwhile, in the inactive keratitis group, 25
(86.2%) corneas belonged to women and only 4
(13.7%) to men with a younger mean age of 39.9
years (range, 7–70 years). Apart from nonspecific
symptoms of dry eye and discomfort, most of these
patients were asymptomatic at the time of the
analysis, and only thosewith corneal scarring along
the visual axis or irregular astigmatism complained
of blurred vision.
SD-OCT Microstructural Analysis for Active
Keratitis
Table 1 shows the frequency of the SD-OCT
morphologic alterations from corneas with active
keratitis. The most common findings were stromal
edema and inflammatory infiltrates seen in 79.1%
of eyes each, followed by epithelial thickening
in 66.6% and stromal scarring in 62.5% of eyes.
Of the seven corneas with active necrotizing
HSK, five (71.4%) showed epithelial ulceration over
the stromal infiltration. Half of the HSK lesions
affected the visual axis, and the other 50% were
located in the paracentral and peripheral cornea.
Additionally, nearly half of the active corneal
lesions were found at mid-stromal depth, had a
medium density, and covered an area between 25
and 45% of the corneas (Table 2).
The corneal shape was distorted within the
affected zones, showing a hypodense and
thickened stroma due to edema. There was
also a higher reflectivity at the site of stromal
inflammatory infiltrates compared to unaffected
areas (Figure 1).
SD-OCT Microstructural Analysis for Inactive
Keratitis
The most common SD-OCT morphologic changes
seen in corneas with inactive keratitis consisted
of stromal scarring (89.6%), epithelial remodeling
(72.4%), and stromal thinning (68.9%) (Table 1).
Similar to the eyes with active HSK, nearly half
of the lesions were located in the visual axis, and
the other 48.3% were located in the paracentral
and peripheral cornea. Additionally, 44.8% of the
lesions extended to the mid-stromal depth and
had a medium density. Finally, most of the inactive
lesions (72.4%) covered an area between 25 and
45% of the ocular surface (Table 2). In general, the
SD-OCT analysis of inactive HSK showed thinner
corneas with stromal compaction due to fibrosis
and scarring. The overlying epithelium was thicker
in the affected areas, showing remodeling and
thickness compensation. Additionally, there was a
higher reflectivity, particularly in areas of dense
leukomas (Figure 2).
SD-OCTMicrostructural Differences Between
Non-necrotizing and Necrotizing HSK
There was a clear difference in the morphologic
appearance between non-necrotizing and
necrotizing keratitis. All corneas with necrotizing
HSK showed severe stromal scarring, and the vast
majority also had significant stromal inflammatory
infiltration and thinning (Table 1). On the other hand,
the non-necrotizing corneas showed significantly
less inflammatory infiltration (P = 0.011).
Following the SD-OCT cross-sectional analysis,
the majority of necrotizing HSK lesions (77.7%)
were located centrally, affecting the visual
axis, and showed a higher density compared
to non-necrotizing lesions (P = 0.01) (Table 2).
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Figure 1. (A) Slit-lamp photograph of a cornea with active necrotizing HSK showing stromal inflammatory infiltration and edema.
(B) SD-OCT pachymetry map showing a thickened cornea (max = 670 µm) corresponding to the area with stromal edema. (C)
A cross-sectional view of the central lesion showing areas of epithelial thickening (max = 76 µm) over inflammatory infiltrates,
corresponding to areas of hyperreflectivity, and hypodense areas, corresponding to stromal edema. (D) Color scale of the same
lesion showing the inflammatory infiltrates and scarring in warm (orange to yellow) tones.
Figure 2. (A) Slit-lamp photograph of a cornea with inactive nonnecrotizing HSK, showing a diffuse leukoma with no stromal
edema. (B) SD-OCT pachymetry showing a thinner cornea (min = 423 µm) in the area of the lesion. (C) A cross-sectional view of
the leukoma showing areas of epithelial remodeling and thickening compensation (max = 83 µm) under areas of scarring and
stromal compaction (min = 470 µm). (D) Color scale of the lesion showing higher density areas corresponding to fibrosis and
scarring on the anterior and medial stroma, fading to yellow and green tones as the lesion becomes less dense.
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Epithelial remodeling 1 (4.1) 21 (72.4) < 0.001* 19 (43.1) 3 (33.3) 0.02*
Epithelial thickening 16 (66.6) 1 (3.4) < 0.001* 13 (29.5) 4 (44.4) 0.387
Epithelial damage (ulceration) 5 (20.8) 0 (0.0) < 0.001* 0 (0.0) 5 (55.5) < 0.001*
Stromal thinning (< 450 µm) 6 (25.0) 20 (68.9) 0.004* 20 (45.4) 7 (77.7) 0.080
Stromal edema (> 570 µm) 19 (79.1) 1 (3.4) < 0.001* 15 (34.0) 4 (44.4) 0.652
Stromal inflammatory infiltration 19 (79.1) 2 (6.8) < 0.001* 14 (31.8) 7 (77.7) 0.011*
Stromal scarring (> 35% surface) 15 (62.5) 26 (89.6) 0.042* 34 (77.2) 9 (100.0) 0.095
SD-OCT, spectral-domain optical coherence tomography; HSK, herpetic stromal keratitis
∗P-value < 0.05 was considered as statistically significant (Mann–Whitney U-test for two independent samples).
Table 2. SD-OCT cross-sectional analysis of most representative corneal lesions (scar, leukoma, or infiltrate) seen in eyes with
herpetic stromal keratitis.














(n = 9 )
P-value
Localization:
- Central (visual axis) 12 (50.0) 15 (51.7) 0.901 20 (45.4) 7 (77.7) 0.08
- Paracentral/peripheral 12 (50.0) 14 (48.3) 0.901 24 (54.6) 2 (22.3) 0.08
Density:
- Low (grade-I, < 33%) 7 (29.1) 10 (34.4) 0.464 17 (36.9) 0 (0.0) 0.040*
- Medium (grade-II, 34–66%) 11 (45.8) 13 (44.8) 0.942 21 (45.7) 3 (33.3) 0.956
- High (grade-III, > 67%) 6 (25.0) 6 (20.6) 0.777 8 (17.4) 6 (66.7) 0.010*
Depth:
- Superficial (< 150 µm) 7 (29.2) 10 (34.5) 0.683 17 (38.6) 0 (0.0) 0.025*
- Medial (150–350 µm) 11 (45.8) 13 (44.8) 0.942 21 (47.7) 3 (33.3) 0.434
- Deep (> 350 µm) 6 (25.0) 6 (20.7) 0.712 6 (13.6) 6 (66.7) 0.001*
Extension:
- Small (< 25% surface) 4 (16.6) 6 (20.6) 0.712 10 (22.7) 0 (0.0) 0.116
- Medium (25–45% surface) 13 (54.1) 21 (72.4) 0.172 30 (68.1) 4 (44.4) 0.18
- Large (> 45% surface) 7 (29.1) 2 (6.8) 0.033* 4 (9.0) 5 (55.5) 0.001*
SD-OCT, spectral-domain optical coherence tomography; HSK, herpetic stromal keratitis
∗P-value < 0.05 was considered as statistically significant (Mann–Whitney U test for two independent samples).
Additionally, 66.7% of the lesions analyzed
were located deep into the corneal stroma
(P = 0.001), and many of them covered a
significant area of the corneal surface (P =
0.001). By contrast, most non-necrotizing lesions
were in the low- to medium-density range,
extended between the superficial to medium
stromal depths, and affected a smaller area of
the cornea than in necrotizing keratitis (Table
2).
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Table 3. Mean pachymetry measurements by SD-OCT of corneas with herpetic stromal keratitis according to inflammatory
status and type of keratitis.




keratitis (n = 24)
Eyes with Inactive
keratitis (n = 29)
P-value Non- necrotizing
keratitis (n = 44)
Necrotizing
keratitis (n = 9)
P-value
CCT 561.7 482.3 < 0.001* 519.7 492.8 O.405
MCT 483.5 436.4 0.007* 468.9 396.3 0.002*
CTL 644.7 439.9 < 0.001* 528.2 473.5 0.711





5 (20.8%) 11 (37.9%)† 0.181 6 (13.6%) 5 (62.5%)† 0.001*
SD-OCT, spectral-domain optical coherence tomography; CCT, central corneal thickness; MCT, minimum corneal thickness; CTL,
corneal thickness at lesion site; CETL, corneal epithelium thickness at lesion site; †confirmed by topography
∗P-value < 0.05 was considered as statistically significant (Mann–Whitney U test for two independent samples).
Figure 3. (A) A cross-sectional image of a cornea with inactive HSK showing epithelial remodeling (top arrow) over a zone of
stromal fibrosis and compaction (bottom arrow) with the MCT = 441 µm. (B) A cross-sectional image of a cornea with active HSK
showing marked stromal edema (CTL = 641 µm) and an active inflammatory infiltrate (bottom arrow) underlying an area of epithelial
edema.
Pachymetry Comparative Analysis
The comparative analysis of corneal thickness
between the active and inactive keratitis groups
showed significant differences in the four
measured parameters: CCT, MCT, CTL, and
CETL (Table 3). Eyes with inactive HSK had
significant stromal thinning compared to those
with active disease (P ≤ 0.007). However, the
corneal epithelial thickness at the site of the
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lesion was significantly increased in the inactive
cases (P = 0.048). On the other hand, the values
of MCT (P = 0.002) and CETL (P = 0.043) were
significantly lower in corneas with necrotizing
keratitis than in non-necrotizing keratitis. Finally,
almost one-third of the eyes showed irregular
astigmatism and severe stromal thinning with a
major predominance in the necrotizing group (P <
0.001).
DISCUSSION
Clinically, the corneal pathologic characteristics
seen in HSK depend on direct slit-
lamp observation of inflammatory stromal
infiltration, edema, neovascularization,
scarring, and thinning with a history of
herpes infection and previously known
herpetic epithelial ulceration and corneal
hypoesthesia.[15, 23]
SD-OCT allows an in vivo, accurate, noncontact,
and fast examination of the entire corneal
microstructure in different inflammatory
pathologies, including HSK.[24–26] To the best
of our knowledge, no systematic microstructural
analyses have been performed of the corneal
pathologic changes seen in HSK using SD-
OCT. In the present study, we described these
changes in different stages of disease activity and
severity. Spectral-domain tomography permits a
detailed analysis of the entire cornea in cross-
sections of variable orientations as well as en face
fragmentation analysis.[24] Most corneas analyzed
in the inactive stage of the disease showed
epithelial remodeling, consisting of thickening
over the scarred stroma that was characterized
by fibrosis, thinning, and compaction (Figure
2).
In contrast, more than two-thirds of the corneas
from patients with active keratitis showed
significant stromal edema characterized by
increased CCT and CTL (Table 3), as well as a
hypodense and thickened stromal appearance
(Figure 1). In general, patients with the inactive
stage of HSK did not show corneal stromal
edema; their CCT measurements were in
the low to normal range (356–537 µm), and
the mean CTL was even lower (439.9 µm),
corresponding to areas of stromal scarring and
thinning.
Corneas from the active keratitis group
showed a thicker epithelium than average
at the site of the lesion (mean CETL = 68.7
µm) and a significantly increased corneal
thickness (mean CTL = 644.7 µm), reflecting
the presence of stromal inflammatory infiltration
and edema.
Of note was the occurrence of severe corneal
thinning in a total of 16 (30.1%) eyes with
HSK, with a higher proportion in corneas with
necrotizing disease (Table 3). Necrotizing HSK,
the most severe form of herpetic keratitis, is
characterized by significant leukocyte stromal
infiltration and tissue necrosis with consequent
thinning of the cornea, which explains the
higher percentage of severe corneal thinning
and irregular astigmatism seen in these
corneas.[7, 27]
SD-OCT measures the intensity of a
backscattered optical signal, which represents the
reflectivity of the tissue.[28] Since reflectivity varies
among different tissues, we can differentiate them
by measuring their reflectivities in transverse scans
that can be displayed as false-color or grayscale
cross-sectional images.[29, 30] The intensity of
the backscattered optical signal is represented
on a logarithmic scale with varying degrees of
brightness. White corresponds to the highest
reflection, while dark gray and black correspond
to weaker back reflection.[30] SD-OCT software
allows toggling between gray- and color scales
for each image created. The color scale allows
easier detection of subtle variations in the OCT
signal to define reflectivity levels. Conversely, the
grayscale allows the viewer to visualize contrast
more easily.[31] We used the color scale to measure
the density of inflammatory infiltrates in eyes with
active keratitis and leukomas or scarring in eyes
with inactive HSK. In both active and inactive
disease, approximately two-thirds of the eyes
showed medium to high density lesions; however,
corneas with necrotizing stromal keratitis had a
significantly higher percentage of high-density
lesions (Table 2).
We found a particular limitation in differentiating
between stromal edema and inflammatory
infiltration in corneas with active keratitis, where
both lesions coexisted within the same stromal
area. However, differences in reflectivity, where
stromal edema appears as a hypodense area of
increased stromal thickness and low reflectivity
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and stromal infiltrates as areas of increased stromal
thickness but with higher reflectivity (yellow-to-
orange color), help to facilitate their differentiation.
Since there are no previous specific reports on
SD-OCT findings in this pathologic condition, we
find the present study of value to improve our
understanding of the in vivo pathologic changes
occurring at different stages and severity of HSK.
As in other corneal pathologies, we consistently
found epithelial remodeling, consisting of zonal
thickening at sites of fibrosis and scarring in
inactive disease (Figure 3A). Epithelial remodeling
has also been observed as a way of anterior
curvature compensation in advanced keratoconus
under areas of significant stromal thinning and
ectasia.[32] In contrast, epithelial thickening was
present in most eyes during active inflammation
(Figure 3B).
In a clinical setting, corneal SD-OCT could be
useful to analyze scarring extension and leukoma
depth, hence facilitating surgical decisions
regarding partial or total corneal transplantation.
Additionally, it may be useful for the detection
and grading of stromal edema during recurrent
inflammation under challenging situations. During
active HSK, leucocyte infiltration induces stromal
edema characterized by diffuse haziness, giving a
“ground glass” appearance in the area surrounding
the inflammatory infiltrate. Subtle stromal edema
may hide in the infiltrate or under a dense
leukoma. In such circumstances, corneal SD-OCT
represents a useful aid for its detection. The
potential limitations of the present study include
distortions that occur in the SD-OCT scans as a
result of the refractive indexes of the tissues. The
acquisition of SD-OCT scans was performed along
meridional planes to minimize this effect, and all
images were de-warped by the SD-OCT system’s
corneal adaptor module software.[31]
In conclusion, in vivo SD-OCT pathologic
analysis of corneas with different disease activity
and types of inflammation has permitted a better
understanding of the pathologic mechanisms
adopted by the affected corneas. Additionally,
it allowed the evaluation of the grade and
extent of tissue damage and repair seen in
HSK. Future studies of HSK imaging analysis with
SD-OCT should be carried out to monitor disease
progression or therapeutic response, including
OCT angiography of the cornea to analyze blood
perfusion and neovascularization responses.
Additionally, the commercial development of
ultra-high-definition OCTs for corneal and anterior
segment imaging analysis surely would yield more
detailed in vivo ultrastructure pathologic changes
occurring in this sight-threatening disease.
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